Compare ROCK & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ROCK | CLDX |
|---|---|---|
| Founded | 1972 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 1993 | 2008 |
| Metric | ROCK | CLDX |
|---|---|---|
| Price | $50.86 | $26.40 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $44.10 |
| AVG Volume (30 Days) | 286.3K | ★ 749.3K |
| Earning Date | 10-30-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $1,383,811,000.00 | $2,599,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.98 | $19.70 |
| P/E Ratio | $381.94 | ★ N/A |
| Revenue Growth | ★ 23.49 | N/A |
| 52 Week Low | $42.86 | $14.40 |
| 52 Week High | $75.08 | $30.50 |
| Indicator | ROCK | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 47.17 | 47.52 |
| Support Level | $48.76 | $24.97 |
| Resistance Level | $51.96 | $27.92 |
| Average True Range (ATR) | 1.57 | 1.17 |
| MACD | 0.45 | -0.19 |
| Stochastic Oscillator | 59.87 | 23.86 |
Gibraltar Industries Inc manufactures and provides products and services for the Renewable energy, Residential, Agtech, and Infrastructure markets. The Renewables Segment is engaged in designing, engineering, manufacturing, and installing solar racking and electrical balance systems. Agtech Segment provides growing and processing solutions including the designing, engineering, manufacturing, full-scope construction, maintenance, and support of greenhouses and indoor growing operations, and botanical extraction systems. It derives key revenue from the Residential segment which offers roof and foundation ventilation products, single point and centralized mail systems electronic package solutions, and Retractable awnings and gutter guards, among other products.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.